Volume 69 Received 29 October 2012 | ||||||||||
| ||||||||||
aKey Laboratory of Luminescence and Real-Time Analysis, Ministry of Education, College of Pharmaceutical Sciences, Southwest University, Chong Qing 400716, People's Republic of China
Correspondence e-mail: ysong@swu.edu.cn
In the title compound, C4H8Cl4NOP, the two chloroethyl groups are not related by crystallographic symmetry. The difference in the conformation of the two groups is shown by their N-C-C-Cl torsion angles of 64.57 (15) and 175.62 (10)°.
The title compound is a precursor used in the synthesis of the antitumor drug cyclophosphamide and its analogues. For information on organophosphorus heterocyclic compounds, see: Surendra Babu et al. (2009
); Srinivasulu et al. (2008
); Krishna et al. (2006
). For the crystal structures of cyclophosphamide analogues, see: Camerman & Camerman (1973
); Jones et al. (1996
); Himes et al. (1982
); Camerman et al. (1983
); Perales & García-Blanco (1977a
,b
); Galdecki & Glowka (1981
); Boyd et al. (1980
); Shih et al. (1986
). For the pharmacological activity of cyclophosphamide analogues, see: Lin et al. (1980
); Borch & Canute (1991
).
|
Data collection: APEX2 (Bruker, 2009
); cell refinement: SAINT (Bruker, 2009
); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
); molecular graphics: SHELXTL (Sheldrick, 2008
); software used to prepare material for publication: SHELXTL and local procedures.
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: FY2076 ).
This work was supported by the Program for New Century Excellent Talents in Universities (NCET-10-0660), the National Scientific & Technological Special Project - Major Creation of New Drugs (Nos. 2010ZX09401-306-1-4 and 2010ZX09401-306-2-19) and the 211 Project of Southwest University (the Third Term).
Borch, R. F. & Canute, G. W. (1991). J. Med. Chem. 34, 3044-3052.
![[ISI]](../../../../../../logos/isiborder.gif)
Boyd, V. L., Zon, G. & Himes, V. L. (1980). J. Med. Chem. 23, 372-375.
![[ISI]](../../../../../../logos/isiborder.gif)
Bruker (2009). APEX2, SADABS and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.
Camerman, N. & Camerman, A. (1973). J. Am. Chem. Soc. 95, 5038-5041.
![[ISI]](../../../../../../logos/isiborder.gif)
Camerman, A., Smith, H. W. & Camerman, N. (1983). J. Med. Chem. 26, 679-683.
![[ISI]](../../../../../../logos/isiborder.gif)
Galdecki, Z. & Glowka, M. L. (1981). Acta Cryst. B37, 1136-1138.
![[details]](../../../../../../b/graphics/details.gif)
Himes, V. L., Mighell, A. D., Stalick, J. K. & Zon, G. (1982). Acta Cryst. B38, 1009-1012.
![[details]](../../../../../../b/graphics/details.gif)
Jones, P. G., Thönnessen, H., Fischer, A., Neda, I., Schmutzler, R., Engel, J., Kutscher, B. & Niemeyer, U. (1996). Acta Cryst. C52, 2359-2363.
![[details]](../../../../../../c/graphics/details.gif)
Krishna, J. R., Krishnaiah, M., Stephen Babu, M., Suresh Reddy, C. & Puranik, V. G. (2006). Acta Cryst. E62, o249-o250.
![[details]](../../../../../../e/graphics/details.gif)
Lin, T. S., Fischer, P. H. & Prusoff, W. H. (1980). J. Med. Chem. 23, 1235-1237.
![[ISI]](../../../../../../logos/isiborder.gif)
Perales, A. & García-Blanco, S. (1977a). Acta Cryst. B33, 1935-1939.
![[ISI]](../../../../../../logos/isiborder.gif)
Perales, A. & García-Blanco, S. (1977b). Acta Cryst. B33, 1939-1943.
![[ISI]](../../../../../../logos/isiborder.gif)
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Shih, Y. E. & Wang, J. S. (1986). Heterocycles, 24, 1599-1603.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Srinivasulu, K., Babu, B. H., Kumar, K. S., Reddy, C. B., Raju, C. N. & Rooba, D. (2008). J. Heterocycl. Chem. 45, 751-757.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Surendra Babu, V. H. H., Krishnaiah, M., Srinivasulu, K., Raju, C. N. & Sreedhar, B. (2009). Acta Cryst. E65, o2700-o2701.
![[details]](../../../../../../e/graphics/details.gif)